P C M van de Kerkhof
Overview
Explore the profile of P C M van de Kerkhof including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
200
Citations
2119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al-Gawahiri M, Al-Gawahiri M, Paller A, Paller A, Skov L, Skov L, et al.
J Am Acad Dermatol
. 2025 Feb;
PMID: 39956196
No abstract available.
2.
Kouwenhoven T, van de Kerkhof P, Kamsteeg M
J Dermatolog Treat
. 2023 Oct;
34(1):2274291.
PMID: 37905412
Background: Chronic pruritus is frequently seen in daily dermatological practice and is associated with marked impact on quality of life. Research on the use of gabapentin and oral antidepressants in...
3.
Ter Haar E, van den Reek J, Ten Bruin E, Bronkhorst E, Borgonjen R, Kleinpenning M, et al.
J Eur Acad Dermatol Venereol
. 2023 Jul;
37(12):e1471-e1474.
PMID: 37471529
No abstract available.
4.
van Winden M, Klosters F, Hamaker M, Olde Rikkert M, van de Kerkhof P, de Jong E, et al.
Br J Dermatol
. 2021 Oct;
186(3):589-591.
PMID: 34698375
No abstract available.
5.
6.
van de Kerkhof P
J Eur Acad Dermatol Venereol
. 2021 Apr;
35(5):1041-1042.
PMID: 33885194
No abstract available.
7.
de Vries F, Driessen R, Welbie M, Tjin E, van de Kerkhof P
J Dermatolog Treat
. 2021 Mar;
32(3):269-276.
PMID: 33754925
Despite the wide range of available treatment modalities a delay between the first outbreak of acne vulgaris and an effective treatment outcome is experienced by many patients. Considering the growing...
8.
Atalay S, van den Reek J, Groenewoud J, van de Kerkhof P, Kievit W, de Jong E
J Dermatolog Treat
. 2020 Dec;
33(3):1591-1597.
PMID: 33356686
Background/objectives: Tightly-controlled dose reduction was possible during 1 year in psoriasis patients on adalimumab, etanercept or ustekinumab with low disease activity (CONDOR trial). Extended observation is needed to ensure long-term...
9.
van Winden M, Ter Haar E, Groenewoud J, van de Kerkhof P, de Jong E, Lubeek S
Br J Dermatol
. 2020 Nov;
184(4):759-762.
PMID: 33152111
No abstract available.
10.
van Winden M, Garcovich S, Peris K, Colloca G, de Jong E, Hamaker M, et al.
J Eur Acad Dermatol Venereol
. 2020 May;
35(1):95-104.
PMID: 32403174
Background: Appropriate management and prevention of both under- and overtreatment in older skin cancer patients can be challenging. It could be helpful to incorporate frailty screening in dermato-oncology care, since...